Sunil Healthcare Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Sunil Healthcare Ltd is ₹ 70 as of 23 Oct 15:30 . The P/E Ratio of Sunil Healthcare Ltd changed from 11.4 on March 2022 to 15.9 on March 2026 . This represents a CAGR of 6.88% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Sunil Healthcare Ltd changed from ₹ 23.43 crore on March 2021 to ₹ 63.55 crore on March 2026 . This represents a CAGR of 18.09% over 6 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Sunil Healthcare Ltd for the Jun '26 is ₹ 19.21 crore as compare to the Mar '26 revenue of ₹ 20.13 crore. This represent the decline of -4.57% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Sunil Healthcare Ltd for the Jun '26 is ₹ 3.15 crore as compare to the Mar '26 ebitda of ₹ 2.23 crore. This represent the growth of 41.26% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Sunil Healthcare Ltd changed from ₹ -0.69 crore to ₹ 0.46 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Sunil Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Sunil Healthcare Ltd

Sunil Healthcare Limited (Formerly known Sunil Synchem Ltd) was incorporated in 1973.
The Company introduced plant at Alwar; Rajasthan for manufacture of Empty Hard Gelatin Capsule Shells and HPMC Capsules Shell.
With continuous efforts and improvements in policy & adherence to top-notch quality monitoring measures, the Company became the second-largest manufacturer of Empty Hard Gelatin Capsules (EHGC) in India. The Company is WHO-GMP certified Company and has also been recognized as 'Star Export House' by GoI. The Company commenced its manufacturing operation in 1976 with installed capacity of 200 million Hard Gelatin Capsule Shell.
With gradual expansion, it reached to the installed capacity of 10930 million capsules p.a.
The product of the Company Hard Gelatin Capsule Shell is used by Pharmaceutical and Food supplement Companies as a container for administering medicines and food supplements.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Sunil Healthcare Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Sunil Healthcare Ltd or Transgene Biotek Ltd?

Market cap of Sunil Healthcare Ltd is 71 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of Sunil Healthcare Ltd and Transgene Biotek Ltd?

The stock performance of Sunil Healthcare Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sunil Healthcare Ltd and Transgene Biotek Ltd?

As of October 25, 2026, the Sunil Healthcare Ltd stock price is INR ₹70.0. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of Sunil Healthcare Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Sunil Healthcare Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.